Index
S&P 500
Market Cap
102.46B
Enterprise Value
157.34B
Income
6.78B
Sales
78.70B
Book/sh
-38.30
Cash/sh
4.71
Employees
320000
IPO
Mar 10, 2011
P/E
15.68
Forward P/E
15.07
PEG
2.03
P/S
1.30
P/B
-
P/C
100.55
P/FCF
17.15
EV/EBITDA
9.96
EV/Sales
2.00
Quick Ratio
0.74
Current Ratio
0.82
Debt/Eq
-
LT Debt/Eq
-
Option/Short
Yes / Yes
EPS (ttm)
30.18
EPS next Y
31.41
EPS next Q
8.15
EPS this Y
6.36%
EPS next Y
4.67%
EPS next 5Y
7.44%
EPS past 3/5Y
13.94% 20.99%
Sales past 3/5Y
7.87% 7.97%
EPS Y/Y TTM
25.54%
Sales Y/Y TTM
5.82%
EPS Q/Q
4.50%
Sales Q/Q
3.59%
Insider Own
33.18%
Insider Trans
0.00%
Inst Own
62.95%
Inst Trans
-1.68%
ROA
11.00%
ROE
-
ROIC
18.69%
Gross Margin
15.31%
Oper. Margin
15.31%
Profit Margin
8.61%
SMA20
3.27%
SMA50
8.19%
SMA200
6.49%
Trades
Shs Outstand
210.88M
Shs Float
144.67M
52W High
556.52 -14.96%
52W Low
353.99 33.69%
Volatility
4.80% 3.07%
ATR (14)
14.81
RSI (14)
60.73
Beta
1.13
Rel Volume
0.85
Avg Volume
1.32M
Volume
1,115,443
Perf Week
0.90%
Perf Month
11.78%
Perf Quarter
16.39%
Perf Half Y
9.27%
Perf YTD
1.37%
Perf Year
1.38%
Perf 3Y
111.90%
Perf 5Y
88.95%
Perf 10Y
512.15%
Prev Close
478.08
Price
473.25
Change %
-1.01%
Analysts 13 incl. previous ratings
Rating Distribution 4 Buy · 8 Hold · 1 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Sep 23, 2026 Initiated B BMO Capital Markets
Outperform $495 +4.6% Jul 08, 2026 Downgrade B Barclays
Overweight → Equal Weight $427 -9.8% Dec 15, 2025 Downgrade M Morgan Stanley
Equal-Weight → Underweight $425 -10.2% Oct 14, 2025 Resumed G Goldman
Buy $470 -0.7% Jul 28, 2025 Downgrade W Wolfe Research
Outperform → Peer Perform Jul 16, 2025 Downgrade B BofA Securities
Buy → Neutral $394 -16.7% May 29, 2025 Upgrade W Wells Fargo
Underweight → Equal Weight $385 -18.6% Apr 15, 2025 Downgrade R Robert W. Baird
Outperform → Neutral $336 -29.0% Dec 17, 2024 Resumed J JP Morgan
Neutral $380 -19.7% Nov 25, 2024 Downgrade W Wells Fargo
Equal Weight → Underweight $400 → $320 -32.4% Nov 22, 2024 Downgrade R Raymond James
Outperform → Mkt Perform Oct 11, 2024 Initiated K KeyBanc Capital Markets
Overweight $475 +0.4% Sep 03, 2024 Initiated M Morgan Stanley
Equal-Weight $427 -9.8% May 30, 2024 Initiated R Robert W. Baird
Outperform $396 -16.3% Mar 06, 2024 Initiated B Barclays
Overweight $356 -24.8% Jan 04, 2024 Downgrade B Bernstein
Outperform → Mkt Perform $277 → $301 -36.4% Dec 11, 2023 Downgrade G Goldman
Buy → Neutral $271 -42.7% Apr 21, 2023 Initiated C Cantor Fitzgerald
Overweight $304 -35.8% Apr 19, 2023 Resumed J JP Morgan
Neutral $257 → $283 -40.2% Jul 06, 2022 Downgrade B BMO Capital Markets
Market Perform → Underperform $233 → $160 -66.2%
Show Previous Ratings
Oct-29-26 11:14AM
08:30AM
Oct-28-26 10:38AM
Oct-27-26 01:55PM
(The Wall Street Journal)
11:53AM
11:06AM
Loading…
11:06AM
08:35AM
(Investor's Business Daily)
07:35AM
(The Wall Street Journal)
07:12AM
07:00AM
Oct-21-26 08:30AM
Sep-30-26 05:03PM
Sep-29-26 04:30PM
Sep-22-26 10:31AM
Sep-16-26 05:05AM
08:30AM
Loading…
Sep-15-26 08:30AM
Sep-09-26 04:30PM
Aug-21-26 04:30PM
Aug-20-26 04:30PM
Aug-19-26 02:07PM
Aug-11-26 05:24AM
Aug-06-26 08:30AM
Aug-04-26 05:01AM
Jul-29-26 07:13AM
Jul-28-26 04:30PM
Jul-27-26 07:36AM
Jul-24-26 05:02PM
09:59AM
07:38AM
07:30AM
04:30PM
Loading…
Jul-14-26 04:30PM
03:45PM
(Investor's Business Daily)
11:31AM
09:38AM
09:16AM
09:08AM
(The Wall Street Journal)
07:35AM
07:30AM
Jul-08-26 09:39AM
Jun-29-26 08:30AM
Jun-24-26 03:09PM
Jun-17-26 05:30AM
(The Wall Street Journal)
Jun-11-26 07:04PM
Jun-09-26 06:27AM
May-27-26 04:30PM
May-19-26 08:30AM
Apr-30-26 04:30PM
Apr-27-26 05:00PM
08:24AM
06:00AM
Apr-25-26 03:04AM
Apr-24-26 09:59AM
07:07AM
07:00AM
Apr-16-26 08:30AM
Apr-01-26 08:30AM
Mar-26-26 04:00PM
Mar-18-26 08:30AM
Mar-11-26 08:05AM
(Investor's Business Daily)
Mar-10-26 09:50AM
08:30AM
Mar-09-26 09:40AM
09:30AM
Mar-08-26 09:33AM
(Investor's Business Daily)
08:00AM
Mar-07-26 03:02PM
(Investor's Business Daily)
08:06AM
(Investor's Business Daily)
08:00AM
(Investor's Business Daily)
Mar-06-26 06:27PM
(Investor's Business Daily)
06:15PM
(Investor's Business Daily)
11:30AM
09:45AM
09:12AM
(Investor's Business Daily)
Mar-04-26 02:19PM
(Investor's Business Daily)
11:30AM
Feb-27-26 12:43PM
11:30AM
06:48AM
Feb-26-26 04:30PM
12:39PM
11:30AM
08:30AM
Feb-24-26 09:30AM
Feb-23-26 04:19PM
(Investor's Business Daily)
Feb-20-26 12:08PM
09:59AM
09:50AM
Feb-19-26 12:34PM
Feb-18-26 09:40AM
Feb-17-26 08:38AM
Feb-16-26 09:45AM
Feb-13-26 09:30AM
Feb-12-26 11:21AM
07:28AM
Feb-10-26 12:23PM
Feb-09-26 02:08PM
Feb-06-26 05:03PM
01:23PM
11:31AM
Feb-03-26 09:50AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Michael S Cuffe Officer Oct 29 '26 Proposed Sale 477.00 11,800 5,628,600 Oct 29 04:18 PM McAlevey Michael R EVP & Chief Legal & Admin Off. Feb 13 '26 Option Exercise 236.61 5,000 1,183,050 13,853 Feb 18 07:18 PM McAlevey Michael R EVP & Chief Legal & Admin Off. Feb 18 '26 Sale 533.37 1,694 903,537 8,853 Feb 18 07:18 PM Michael R McAlevey OFFICER Feb 18 '26 Proposed Sale 533.34 1,694 903,486 Feb 18 04:18 PM Wyatt Christopher F. SVP & Controller Feb 11 '26 Sale 505.00 4,000 2,020,000 44,379 Feb 12 06:55 PM Berres Jennifer SVP & Chief Human Res. Officer Feb 11 '26 Sale 514.58 8,020 4,126,950 11,993 Feb 12 06:36 PM Jennifer L. Berres OFFICER Feb 11 '26 Proposed Sale 514.58 8,020 4,126,950 Feb 11 04:37 PM Wyatt Christopher F. SVP & Controller Feb 05 '26 Option Exercise 139.06 10,670 1,483,770 51,737 Feb 09 06:13 PM Foster Jon M EVP and COO Feb 05 '26 Option Exercise 139.06 29,330 4,078,630 29,330 Feb 09 06:08 PM HAZEN SAMUEL N CEO Feb 03 '26 Sale 501.04 42,877 21,483,275 32,276 Feb 05 06:33 PM Cuffe Michael S. EVP and Chief Clinical Officer Feb 03 '26 Sale 498.09 1,500 747,135 30,003 Feb 05 06:22 PM MICHAEL S CUFFE OFFICER Feb 03 '26 Proposed Sale 498.09 1,500 747,135 Feb 03 04:36 PM Samuel N. Hazen President, Chief Executive Off Feb 03 '26 Proposed Sale 501.04 42,877 21,483,274 Feb 03 04:33 PM HAZEN SAMUEL N CEO Jan 30 '26 Option Exercise 81.96 84,360 6,914,146 116,636 Feb 02 06:49 PM McAlevey Michael R EVP & Chief Legal & Admin Off. Nov 03 '25 Option Exercise 236.61 13,170 3,116,154 16,657 Nov 05 06:15 PM McAlevey Michael R EVP & Chief Legal & Admin Off. Nov 05 '25 Sale 473.79 3,892 1,843,991 3,487 Nov 05 06:15 PM Michael R McAlevey OFFICER Nov 05 '25 Proposed Sale 473.79 3,892 1,843,991 Nov 05 05:14 PM HAZEN SAMUEL N CEO Oct 31 '25 Option Exercise 69.58 58,050 4,039,119 75,279 Nov 04 06:16 PM
HCA Healthcare, Inc. is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.
CEO & Director Mr. Samuel N. Hazen
CFO & Executive VP Mr. Michael A. Marks
Executive VP & COO Mr. Jon Mack Foster
Executive VP and Chief Legal & Administrative Officer Mr. Michael R. McAlevey
M.D. Dr. Michael S. Cuffe M.B.A.